Search
5 results for “GLP-1”
Mercado Livre Enters Prescription Drug Sales, Sends Brazilian Pharmacy Stocks Tumbling
Latin America’s e-commerce giant, Mercado Livre, will begin selling prescription drugs requiring a retained medical script in Brazil, including GLP-1 weight-loss pens and antibiotics, causing competitor stock prices to fall sharply.
Lula Pledges Free GLP-1 Weight-Loss Drugs via Brazil’s Public Health System (SUS)
President Lula announced that costly GLP-1 obesity treatments will be provided free of charge through Brazil’s Unified Health System (SUS) for severely obese patients.
GLP-1 Weight Loss Drugs Drive New Sales Boom for Brazil’s Pharmacy Giants
Surging demand for GLP-1 treatments like Mounjaro and generic alternatives is fueling double-digit sales growth for major Brazilian drugstore chains.
Mounjaro Launch Fuels Surge in Brazilian Pharmacy Sales as GLP-1 Battle Intensifies
Eli Lilly's tirzepatide, Mounjaro, has become a high-margin sales driver for major Brazilian pharmacy chains like Raia Drogasil.
Mercado Livre Ozempic Deal Sparks Overdone Drugstore Selloff
Brazilian pharmacy stocks RD Saúde and Pague Menos fell on Mercado Livre's Mexican GLP-1 deal, but analysts say strict domestic regulations protect local players.